These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15240608)

  • 21. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease.
    Tan RS; Pu SJ
    Aging Male; 2003 Mar; 6(1):13-7. PubMed ID: 12809076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.
    Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do androgens regulate growth hormone-binding protein in adult man?
    Ip TP; Hoffman DM; O'Sullivan AJ; Leung KC; Ho KK
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1278-82. PubMed ID: 7714101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
    Tripathy D; Shah P; Lakshmy R; Reddy KS
    Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of androgen and atherosclerosis in old-age male.
    Yang YM; Lv XY; Huang WD; Xu ZR; Wu LJ
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):931-5. PubMed ID: 16130198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men.
    Berg G; Schreier L; Geloso G; Otero P; Nagelberg A; Levalle O
    Horm Metab Res; 2002 Feb; 34(2):87-92. PubMed ID: 11972293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury.
    Bauman WA; Cirnigliaro CM; La Fountaine MF; Jensen AM; Wecht JM; Kirshblum SC; Spungen AM
    Horm Metab Res; 2011 Jul; 43(8):574-9. PubMed ID: 21717386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men.
    Bhasin S; Swerdloff RS; Steiner B; Peterson MA; Meridores T; Galmirini M; Pandian MR; Goldberg R; Berman N
    J Clin Endocrinol Metab; 1992 Jan; 74(1):75-83. PubMed ID: 1727832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
    Bloch M; Rubinow DR; Berlin K; Kevala KR; Kim HY; Schmidt PJ
    Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency.
    Corrales JJ; Almeida M; Miralles JM; Orfao A
    Fertil Steril; 2009 Jul; 92(1):311-9. PubMed ID: 18710716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis.
    Cetinkaya B; Guzeldemir E; Ogus E; Bulut S
    J Periodontol; 2013 Jan; 84(1):84-93. PubMed ID: 22414257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.
    Sih R; Morley JE; Kaiser FE; Perry HM; Patrick P; Ross C
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1661-7. PubMed ID: 9177359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.
    Madej A; Okopien B; Kowalski J; Zielinski M; Wysocki J; Szygula B; Kalina Z; Herman ZS
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):345-9. PubMed ID: 9660044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.